Farm bill finds foes

The farm bill is out, with a markup scheduled in a week, but MAHA is ramping up for a bigger fight over its language on ...
National Law Review

New Foreign Ownership and Foreign Adversary Control Rules Adopted for FCC Authorization Holders

The Federal Communications Commission has adopted two orders that materially update regulatory obligations for FCC ...
Le Lézard

FDA approves RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...

Decipher Zone Technologies Expands Global Delivery Capacity for Custom Software Development Services in 2026

Worldwide engineering teams support AI development services, SaaS product development, and enterprise software ...

Johnson & Johnson: FDA approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...